Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Incidence and general hospital costs of self-harm across England: estimates based on the multicentre study of self-harm.

Tsiachristas A, Geulayov G, Casey D, Ness J, Waters K, Clements C, Kapur N, McDaid D, Brand F, Hawton K.

Epidemiol Psychiatr Sci. 2020 Mar 12;29:e108. doi: 10.1017/S2045796020000189.

PMID:
32160934
2.

The economic impact of violence perpetration in severe mental illness: a retrospective, prevalence-based analysis in England and Wales.

Senior M, Fazel S, Tsiachristas A.

Lancet Public Health. 2020 Feb;5(2):e99-e106. doi: 10.1016/S2468-2667(19)30245-2.

3.

Impact of transforming mental health services for young people in England on patient access, resource use and health: a quasi-experimental study.

Rocks S, Fazel M, Tsiachristas A.

BMJ Open. 2020 Jan 15;10(1):e034067. doi: 10.1136/bmjopen-2019-034067.

4.

Effective coverage and budget implications of skill-mix change to improve neonatal nursing care: an explorative simulation study in Kenya.

Tsiachristas A, Gathara D, Aluvaala J, Chege T, Barasa E, English M.

BMJ Glob Health. 2019 Dec 2;4(6):e001817. doi: 10.1136/bmjgh-2019-001817. eCollection 2019.

5.

Suicide following presentation to hospital for non-fatal self-harm in the Multicentre Study of Self-harm: a long-term follow-up study.

Geulayov G, Casey D, Bale L, Brand F, Clements C, Farooq B, Kapur N, Ness J, Waters K, Tsiachristas A, Hawton K.

Lancet Psychiatry. 2019 Dec;6(12):1021-1030. doi: 10.1016/S2215-0366(19)30402-X. Epub 2019 Nov 6.

PMID:
31706930
6.

Variation in spend on young mental health across Clinical Commissioning Groups in England: a cross-sectional observational study.

Rocks S, Fazel M, Tsiachristas A.

BMJ Open. 2019 Oct 7;9(10):e030011. doi: 10.1136/bmjopen-2019-030011.

7.

Methodological Quality of Economic Evaluations in Integrated Care: Evidence from a Systematic Review.

Kadu M, Ehrenberg N, Stein V, Tsiachristas A.

Int J Integr Care. 2019 Sep 9;19(3):17. doi: 10.5334/ijic.4675.

8.

Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs.

Keng MJ, Tsiachristas A, Leal J, Gray A, Mihaylova B.

Diabetes Obes Metab. 2019 Nov;21(11):2405-2412. doi: 10.1111/dom.13821. Epub 2019 Jul 21.

PMID:
31264761
9.

Should I stay or should I go? A retrospective propensity score-matched analysis using administrative data of hospital-at-home for older people in Scotland.

Tsiachristas A, Ellis G, Buchanan S, Langhorne P, Stott DJ, Shepperd S.

BMJ Open. 2019 May 9;9(5):e023350. doi: 10.1136/bmjopen-2018-023350.

10.

Comprehensive Geriatric Assessment in hospital and hospital-at-home settings: a mixed-methods study.

Gardner M, Shepperd S, Godfrey M, Mäkelä P, Tsiachristas A, Singh-Mehta A, Ellis G, Khanna P, Langhorne P, Makin S, Stott DJ.

Southampton (UK): NIHR Journals Library; 2019 Mar.

11.

Preventing PTSD, depression and associated health problems in student paramedics: protocol for PREVENT-PTSD, a randomised controlled trial of supported online cognitive training for resilience versus alternative online training and standard practice.

Wild J, El-Salahi S, Tyson G, Lorenz H, Pariante CM, Danese A, Tsiachristas A, Watkins E, Middleton B, Blaber A, Ehlers A.

BMJ Open. 2018 Dec 31;8(12):e022292. doi: 10.1136/bmjopen-2018-022292.

12.

Understanding and evaluating new models of Child and Adolescent Mental Health Services in South-East England: a study protocol for an observational mixed-methods study.

Rocks S, Stepney M, Glogowska M, Fazel M, Tsiachristas A.

BMJ Open. 2018 Dec 4;8(12):e024230. doi: 10.1136/bmjopen-2018-024230.

13.

Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA).

Rutten-van Mölken M, Leijten F, Hoedemakers M, Tsiachristas A, Verbeek N, Karimi M, Bal R, de Bont A, Islam K, Askildsen JE, Czypionka T, Kraus M, Huic M, Pitter JG, Vogt V, Stokes J, Baltaxe E; SELFIE consortium.

BMC Health Serv Res. 2018 Jul 24;18(1):576. doi: 10.1186/s12913-018-3367-4. Review.

14.

Towards incentivising integration: A typology of payments for integrated care.

Stokes J, Struckmann V, Kristensen SR, Fuchs S, van Ginneken E, Tsiachristas A, Rutten van Mölken M, Sutton M.

Health Policy. 2018 Sep;122(9):963-969. doi: 10.1016/j.healthpol.2018.07.003. Epub 2018 Jul 11. Review.

15.

Cost-effectiveness of cognitive-behavioural therapy for sleep disorder added to usual care in patients with schizophrenia: the BEST study.

Tsiachristas A, Waite F, Freeman D, Luengo-Fernandez R.

BJPsych Open. 2018 Apr 19;4(3):126-135. doi: 10.1192/bjo.2018.2. eCollection 2018 May.

16.

Tackling the challenge of multi-morbidity: Actions for health policy and research.

Tsiachristas A, van Ginneken E, Rijken M.

Health Policy. 2018 Jan;122(1):1-3. doi: 10.1016/j.healthpol.2017.11.011. Epub 2017 Nov 29. No abstract available.

PMID:
29217111
17.

Understanding the true economic impact of self-harming behaviour - Authors' reply.

McDaid D, Tsiachristas A, Hawton K.

Lancet Psychiatry. 2017 Dec;4(12):901. doi: 10.1016/S2215-0366(17)30440-6. No abstract available.

PMID:
29179930
18.

Comprehensive geriatric assessment for older adults admitted to hospital.

Ellis G, Gardner M, Tsiachristas A, Langhorne P, Burke O, Harwood RH, Conroy SP, Kircher T, Somme D, Saltvedt I, Wald H, O'Neill D, Robinson D, Shepperd S.

Cochrane Database Syst Rev. 2017 Sep 12;9:CD006211. doi: 10.1002/14651858.CD006211.pub3. Review.

19.

General hospital costs in England of medical and psychiatric care for patients who self-harm: a retrospective analysis.

Tsiachristas A, McDaid D, Casey D, Brand F, Leal J, Park AL, Geulayov G, Hawton K.

Lancet Psychiatry. 2017 Oct;4(10):759-767. doi: 10.1016/S2215-0366(17)30367-X. Epub 2017 Sep 8.

20.

The SELFIE framework for integrated care for multi-morbidity: Development and description.

Leijten FRM, Struckmann V, van Ginneken E, Czypionka T, Kraus M, Reiss M, Tsiachristas A, Boland M, de Bont A, Bal R, Busse R, Rutten-van Mölken M; SELFIE consortium.

Health Policy. 2018 Jan;122(1):12-22. doi: 10.1016/j.healthpol.2017.06.002. Epub 2017 Jun 20.

21.

Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC).

Tsiachristas A, Gittins M, Kitchener H, Gray A.

J Med Screen. 2018 Jun;25(2):99-109. doi: 10.1177/0969141317704679. Epub 2017 May 22.

22.

Financial Incentives to Stimulate Integration of Care.

Tsiachristas A.

Int J Integr Care. 2016 Oct 28;16(4):8. doi: 10.5334/ijic.2532. No abstract available.

23.

Performing Economic Evaluation of Integrated Care: Highway to Hell or Stairway to Heaven?

Tsiachristas A, Stein KV, Evers S, Rutten-van Mölken M.

Int J Integr Care. 2016 Oct 19;16(4):3. doi: 10.5334/ijic.2472.

24.

Economic impact of early intervention in psychosis services: results from a longitudinal retrospective controlled study in England.

Tsiachristas A, Thomas T, Leal J, Lennox BR.

BMJ Open. 2016 Oct 20;6(10):e012611. doi: 10.1136/bmjopen-2016-012611.

25.

A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).

Kitchener HC, Gittins M, Rivero-Arias O, Tsiachristas A, Cruickshank M, Gray A, Brabin L, Torgerson D, Crosbie EJ, Sargent A, Roberts C.

Health Technol Assess. 2016 Sep;20(68):1-138. doi: 10.3310/hta20680.

26.

B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?

Tsiachristas A, Smith AD.

Alzheimers Dement (N Y). 2016 Aug 11;2(3):156-161. doi: 10.1016/j.trci.2016.07.002. eCollection 2016 Sep. Review.

27.

Bridging knowledge to develop an action plan for integrated care for chronic diseases in Greece.

Tsiachristas A, Lionis C, Yfantopoulos J.

Int J Integr Care. 2015 Oct 22;15:e040. eCollection 2015 Oct-Dec.

28.

Impact of financial agreements in European chronic care on health care expenditure growth.

Tsiachristas A, Dikkers C, Boland MR, Rutten-van Mölken MP.

Health Policy. 2016 Apr;120(4):420-30. doi: 10.1016/j.healthpol.2016.02.012. Epub 2016 Mar 2.

PMID:
26971018
29.

Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.

Tsiachristas A, Burgers L, Rutten-van Mölken MP.

Value Health. 2015 Dec;18(8):977-86. doi: 10.1016/j.jval.2015.07.007. Epub 2015 Sep 16.

30.

Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial.

Boland MR, Kruis AL, Huygens SA, Tsiachristas A, Assendelft WJ, Gussekloo J, Blom CM, Chavannes NH, Rutten-van Mölken MP.

NPJ Prim Care Respir Med. 2015 Dec 17;25:15071. doi: 10.1038/npjpcrm.2015.71.

31.

Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial.

Boland MR, Kruis AL, Tsiachristas A, Assendelft WJ, Gussekloo J, Blom CM, Chavannes NH, Rutten-van Mölken MP.

BMJ Open. 2015 Nov 1;5(10):e007284. doi: 10.1136/bmjopen-2014-007284.

32.

Payment and economic evaluation of integrated care.

Tsiachristas A.

Int J Integr Care. 2015 Apr 22;15:e013. eCollection 2015 Apr-Jun. No abstract available.

33.

Costs and effects of new professional roles: Evidence from a literature review.

Tsiachristas A, Wallenburg I, Bond CM, Elliot RF, Busse R, van Exel J, Rutten-van Mölken MP, de Bont A; MUNROS team.

Health Policy. 2015 Sep;119(9):1176-87. doi: 10.1016/j.healthpol.2015.04.001. Epub 2015 Apr 13. Review.

PMID:
25899880
34.

Cost-Effectiveness of a COPD Disease Management Program in Primary Care: The Recode Cluster Randomized Trial.

Boland MR, Kruis A, Tsiachristas A, Assendelft W, Gussekloo J, Blom C, Chavannes N, Rutten van-Molken M.

Value Health. 2014 Nov;17(7):A595. doi: 10.1016/j.jval.2014.08.2050. Epub 2014 Oct 26. No abstract available.

35.

Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs: A Dutch Demonstration Study Using the Analytic Hierarchy Process Method.

Trip AM, Tsiachristas A, Koenders JM, Kanters TA.

Value Health. 2014 Nov;17(7):A541-2. doi: 10.1016/j.jval.2014.08.1744. Epub 2014 Oct 26. No abstract available.

36.

Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands.

Tsiachristas A, Burgers LT, Rutten-van MM.

Value Health. 2014 Nov;17(7):A498. doi: 10.1016/j.jval.2014.08.1489. Epub 2014 Oct 26. No abstract available.

37.

Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands.

Tsiachristas A, Waters BH, Adams SA, Bal R, Mölken MP.

BMC Health Serv Res. 2014 Oct 26;14:518. doi: 10.1186/s12913-014-0518-0.

38.

Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial.

Kruis AL, Boland MR, Assendelft WJ, Gussekloo J, Tsiachristas A, Stijnen T, Blom C, Sont JK, Rutten-van Mölken MP, Chavannes NH.

BMJ. 2014 Sep 10;349:g5392. doi: 10.1136/bmj.g5392.

39.

Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants.

Tsiachristas A, Cramm JM, Nieboer AP, Rutten-van Mölken MP.

Cost Eff Resour Alloc. 2014 Jul 28;12:17. doi: 10.1186/1478-7547-12-17. eCollection 2014.

40.

The role of disease management programs in the health behavior of chronically ill patients.

Cramm JM, Adams SA, Walters BH, Tsiachristas A, Bal R, Huijsman R, Rutten-Van Mölken MP, Nieboer AP.

Patient Educ Couns. 2014 Apr;95(1):137-42. doi: 10.1016/j.pec.2013.12.017. Epub 2014 Jan 10.

41.

Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study.

Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Mölken MP.

Prim Care Respir J. 2014 Mar;23(1):30-7. doi: 10.4104/pcrj.2014.00002.

42.

The management of cardiovascular disease in the Netherlands: analysis of different programmes.

Cramm JM, Tsiachristas A, Walters BH, Adams SA, Bal R, Huijsman R, Rutten-Van Mölken MP, Nieboer AP.

Int J Integr Care. 2013 Aug 7;13:e028. eCollection 2013.

43.

Exploring payment schemes used to promote integrated chronic care in Europe.

Tsiachristas A, Dikkers C, Boland MR, Rutten-van Mölken MP.

Health Policy. 2013 Dec;113(3):296-304. doi: 10.1016/j.healthpol.2013.07.007. Epub 2013 Aug 12. Review.

PMID:
23937868
44.

The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis.

Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Mölken MP.

BMC Pulm Med. 2013 Jul 3;13:40. doi: 10.1186/1471-2466-13-40. Review.

45.

Broader economic evaluation of disease management programs using multi-criteria decision analysis.

Tsiachristas A, Cramm JM, Nieboer A, Rutten-van Mölken M.

Int J Technol Assess Health Care. 2013 Jul;29(3):301-8. doi: 10.1017/S0266462313000202. Epub 2013 Jun 12.

PMID:
23759317
46.

RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care.

Kruis AL, Boland MR, Schoonvelde CH, Assendelft WJ, Rutten-van Mölken MP, Gussekloo J, Tsiachristas A, Chavannes NH.

BMC Pulm Med. 2013 Mar 23;13:17. doi: 10.1186/1471-2466-13-17.

47.

Development and validation of a short version of the Assessment of Chronic Illness Care (ACIC) in Dutch disease management programs.

Cramm JM, Strating MM, Tsiachristas A, Nieboer AP.

Health Qual Life Outcomes. 2011 Jul 4;9:49. doi: 10.1186/1477-7525-9-49.

48.

Towards integrated care for chronic conditions: Dutch policy developments to overcome the (financial) barriers.

Tsiachristas A, Hipple-Walters B, Lemmens KM, Nieboer AP, Rutten-van Mölken MP.

Health Policy. 2011 Jul;101(2):122-32. doi: 10.1016/j.healthpol.2010.10.013. Epub 2010 Nov 9.

PMID:
21067841
49.

Potential barriers to the application of multi-factor portfolio analysis in public hospitals: evidence from a pilot study in the Netherlands.

Pavlova M, Tsiachristas A, Vermaeten G, Groot W.

Int J Health Plann Manage. 2009 Jan-Mar;24(1):43-68. doi: 10.1002/hpm.929.

PMID:
18435431

Supplemental Content

Loading ...
Support Center